These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 6594194)
1. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Koeffler HP; Hirji K; Itri L Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438 [TBL] [Abstract][Full Text] [Related]
3. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis. Qi DY; Perkins SL; Kling SJ; Russell RG J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520 [TBL] [Abstract][Full Text] [Related]
4. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Gniadecki R Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225 [TBL] [Abstract][Full Text] [Related]
5. Effect of 1,25(OH)2D3 on normal human CFU-GM: target cells of the agent in the suppression of colony formation and induction of macrophage colonies. Takahashi T; Suzuki A; Ichiba S; Okuno Y; Sugiyama H; Imura H; Nakamura K; Iho S; Hoshino T Int J Hematol; 1991 Feb; 54(1):57-63. PubMed ID: 1954352 [TBL] [Abstract][Full Text] [Related]
6. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3. Miyaura C; Abe E; Suda T; Kuroki T Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776 [TBL] [Abstract][Full Text] [Related]
7. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Lee YY; Kim ES; Seol JG; Kim BK; Binderup L; Elstner E; Park DJ; Koeffler HP Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678 [TBL] [Abstract][Full Text] [Related]
8. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time. Okuno S; Inaba M; Nishizawa Y; Morii H Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452 [TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 and the regulation of the differentiation and function of macrophages and granulocytes. Shezen E; Goldman R Int J Cell Cloning; 1985 Mar; 3(2):65-80. PubMed ID: 3839007 [TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-macrophages. Choudhuri U; Adams JA; Byrom N; McCarthy DM; Barrett J Haematologia (Budap); 1990; 23(1):9-19. PubMed ID: 2397925 [TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures. Dorshkind K; Reichel H; Norman AW Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458 [TBL] [Abstract][Full Text] [Related]
12. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes. Nagler A; Rikilis I; Tatarsky I; Fabian I J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327 [TBL] [Abstract][Full Text] [Related]
13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]]. Irino S; Taoka T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981 [TBL] [Abstract][Full Text] [Related]
15. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. McCarthy D; Hibbin J; San Miguel JF; Freake H; Rodrigues B; Andrews C; Pinching A; Catovsky D; Goldman JM Int J Cell Cloning; 1984 Jul; 2(4):227-42. PubMed ID: 6086776 [TBL] [Abstract][Full Text] [Related]
16. Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3. Nagler A; Merchav S; Fabian I; Tatarsky I; Weisman Y; Hochberg Z Br J Haematol; 1987 Nov; 67(3):267-71. PubMed ID: 2825755 [TBL] [Abstract][Full Text] [Related]
17. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells. Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias. Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201 [TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998 [TBL] [Abstract][Full Text] [Related]
20. 1 alpha, 25-Dihydroxyvitamin D3 augments clonal growth of macrophages from rat bone marrow progenitor cells and modulates their function. Shezen E; Goldman R Int J Cell Cloning; 1986 Mar; 4(2):115-25. PubMed ID: 3754272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]